Pharma BD Deal Intelligence

Astellas Pharma Inc. / Audentes Therapeutics

2019 · Acquisition/Merger · $3.0B · Complete

Announcement Sentiment

75

Strongly positive

Outcome Score

23

Did not work — the deal failed to deliver.

Astellas acquired Audentes Therapeutics for ~$3B for gene therapy.

Key facts

Announced Dec 02, 2019
Closed Jan 15, 2020
Deal value $3.0B
Deal type Acquisition/Merger
Therapeutic area Gene Therapy

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals